|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 4.240 USD | -1.40% |
|
-2.64% | -40.11% |
Company Valuation: Bicycle Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,790 | 878.8 | 767 | 966.6 | 491.1 | 301 | - | - |
| Change | - | -50.89% | -12.72% | 26.03% | -49.19% | -38.72% | - | - |
| Enterprise Value (EV) 1 | 1,381 | 570 | 280.6 | 91.11 | -122.9 | -211.8 | -102.4 | 16.2 |
| Change | - | -58.72% | -50.76% | -67.53% | -234.87% | -72.38% | 51.67% | 115.83% |
| P/E | -22.8x | -7.79x | -3.56x | -4.83x | -2.24x | -1.63x | -1.81x | -1.61x |
| PBR | 4.41x | 3.24x | 2.07x | 1.03x | 0.81x | 0.53x | 0.63x | 0.77x |
| PEG | - | -0.2x | -0.1x | 0.1x | -0.25x | 0.1x | 0.2x | -0.1x |
| Capitalization / Revenue | 153x | 60.8x | 28.4x | 27.4x | 6.77x | 17.2x | 45x | 19.3x |
| EV / Revenue | 118x | 39.4x | 10.4x | 2.58x | -1.69x | -12.1x | -15.3x | 1.04x |
| EV / EBITDA | -21.5x | -5.05x | -1.53x | -0.45x | 0.51x | 1.53x | 0.59x | -0.09x |
| EV / EBIT | -21x | -4.89x | -1.48x | -0.43x | 0.5x | 1.13x | 0.54x | -0.08x |
| EV / FCF | -82.1x | -5.42x | -4.42x | -0.55x | 0.49x | 1.38x | 0.7x | -0.11x |
| FCF Yield | -1.22% | -18.4% | -22.6% | -182% | 205% | 72.2% | 142% | -938% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.67 | -3.8 | -5.08 | -2.9 | -3.16 | -2.602 | -2.341 | -2.641 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 11.7 | 14.46 | 26.98 | 35.28 | 72.59 | 17.53 | 6.689 | 15.61 |
| EBITDA 1 | -64.21 | -113 | -183.4 | -202.7 | -240.6 | -138.5 | -172.9 | -172.9 |
| EBIT 1 | -65.62 | -116.7 | -189.9 | -209.9 | -247.1 | -187.2 | -190.1 | -209.9 |
| Net income 1 | -66.82 | -112.7 | -180.7 | -169 | -219 | -172.1 | -175.1 | -199 |
| Net Debt 1 | -408.8 | -308.8 | -486.3 | -875.5 | -614 | -512.8 | -403.4 | -284.8 |
| Reference price 2 | 60.870 | 29.600 | 18.080 | 14.000 | 7.080 | 4.240 | 4.240 | 4.240 |
| Nbr of stocks (in thousands) | 29,400 | 29,689 | 42,422 | 69,046 | 69,368 | 69,993 | - | - |
| Announcement Date | 3/1/22 | 2/28/23 | 2/20/24 | 2/25/25 | 3/17/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.65x | -12.08x | 1.53x | - | 301M | |
| 20.44x | 7.17x | 14.49x | 1.43% | 68.87B | |
| 37.07x | 9.67x | 29.5x | 0.04% | 65.29B | |
| -77.51x | 14.96x | -72.15x | -.--% | 27.65B | |
| 29.76x | 6.36x | 16.52x | -.--% | 25.77B | |
| -15.9x | 6.16x | -7.74x | -.--% | 26.08B | |
| 27.51x | 5.14x | 17.12x | -.--% | 20.14B | |
| 49.22x | 18.16x | 36.83x | 0.31% | 17.03B | |
| 1298.7x | 37.56x | 819.65x | -.--% | 15.03B | |
| 18.08x | 5.39x | 12.58x | -.--% | 14.5B | |
| Average | 138.57x | 9.85x | 86.83x | 0.2% | 28.07B | |
| Weighted average by Cap. | 82.68x | 10.39x | 52.11x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BCYC Stock
- Valuation Bicycle Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
